金域医学

603882.SH

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健提供商与服务 > 保健护理服务

公司是一家以第三方医学检验及病理诊断业务为核心的高科技服务企业，通过不断积累的“大平台、大网络、大服务、大样本和大数据”等核心资源优势，致力于为全国各级医疗机构提供领先的医学诊断信息整合服务。公司核心创业团队自上世纪90年代即积极探索医学检验外包服务在中国的运营模式，开创了国内第三方医学检验行业的先河。公司严格遵循国际标准，建立先进的质量管理体系，持续获得国内外权威机构认证认可，连续多年领先行业。通过自主创新、产学研协同创新和开放创新，公司可提供丰富的医学检测和病理诊断项目，检测结果可为全球多个国家和地区认可。公司在国内及香港地区建立了多家医学实验室及合作共建实验室，并以临床和疾病为导向，为全国超过两万家医疗机构提供“全生命周期、全疾病覆盖、全诊疗管理”的医学检验及病理诊断服务，将优质服务延伸至基层，让医学检测更加普惠可及。公司注重人才建设，拥有国际化高端人才和研发团队，并成立了由钟南山院士担任主席、多位院士担任顾问、众多行业顶级专家组成的学术委员会。公司拥有医学检验及检验+AI技术平台，先后被认定为国家企业技术中心、国家高新技术企业、国家基因检测技术应用示范中心等，获批建立多个国家、省部级的研发机构和研发平台。近年来，公司正全面推进医检4.0战略，加快推动大样本、大数据在临床研究、医检技术创新、人工智能和数据要素等领域的开发与应用，打造数据驱动的智慧医检新生态，助力精准诊断、共创价值医疗。

ESG Score Industry Ranking:
7 / 118 (医疗保健提供商与服务)

ESG Rating Distribution(医疗保健提供商与服务)

AAA

2.54%

17.80%

23.73%

BBB

31.36%

17.80%

1.69%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：7.83Updated on 2026-10-29

07.8310

Management & Practices Score：4.89Updated on 2026-09-06

04.897

Controversies Score：2.94Updated on 2026-10-29

02.943

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	4.05	3.34	5.17%
Social	7.26	3.84	67.23%
Governance	6.89	5.25	27.59%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(118 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	300143.SZ	盈康生命	AA	8.89	3.00	5.89	7.09	8.82	7.68
2	2325.HK	云康集团	AA	8.19	2.99	5.19	5.36	7.87	6.73
3	300015.SZ	爱尔眼科	AA	8.17	2.99	5.18	6.28	7.34	7.75
4	9860.HK	艾迪康控股	A	7.97	3.00	4.97	3.99	7.26	7.29
5	000963.SZ	华东医药	A	7.94	3.00	4.94	5.39	7.03	7.45
6	000950.SZ	重药控股	A	7.84	2.99	4.85	5.54	7.03	6.95
7	603882.SH	金域医学	A	7.83	2.94	4.89	4.05	7.26	6.89
8	301103.SZ	何氏眼科	A	7.82	2.98	4.84	4.10	7.35	6.40
9	600056.SH	中国医药	A	7.63	2.99	4.63	4.83	6.45	7.38
10	2666.HK	环球医疗	A	7.61	3.00	4.61	3.78	6.81	6.57